LOS ANGELES, June 6

(Reuters) - Aspreva Pharmaceuticals Corp. on Wednesday

said Las Vegas Hotels. Save More on

the US Food and Drug Administration has granted fast-track status to its ... CellCept linked to miscarriage and congenital malformations. Unique agreement between Roche and Aspreva to develop CellCept in autoimmune diseases. ... CellCept is the leading immunosuppressant in transplantation. ...

Data presented today1 at the International Society for Heart and Lung Transplantation (ISHLT) annual meeting strengthens the body of evidence that CellCept Recently, the results of a multicenter trial comparing the efficacy and safety of mycophenolate mofetil (CellCept, Roche) to that of enteric-coated ... Malignant Disease and Immune-Suppression. CellCept (Mycophenolate mofetil) is an immunosuppressant drug used to prevent the rejection in organ transplant. CellCept ® (mycophenolate mofetil) is a medication given to people who have received kidney, heart or liver transplants to help keep their

new organ(s) ... Roche's Cellcept linked by FDA to increased miscarriage, birth defects◄:: ZURICH (Thomson Financial) - Roche Holdings AG's CellCept drug could increase the ... CellCept (mycophenolate mofetil) drug information, dosage, side effects, drug interactions, and warnings. CellCept, generic name mycophenolate mofetil, About CellCept CellCept is an immunosuppressant or "anti-rejection" drug used in combination with other immunosuppressive drugs (cyclosporine and ... The 370-patient, 24-week, randomized, open-label study failed to prove that CellCept was superior to intravenous cyclophosphamide (IVC), a cancer drug used ... CellCept (Mycophenolate Mofetil) Study for Lupus Nephritis,

Arthritis,

Treating lupus patients suffering from kidney inflammation (lupus nephritis) with ... Roche's Cellcept linked by FDA to increased miscarriage, birth defects◄:: ZURICH (Thomson Financial)
—- Roche Holdings AG's

CellCept drug could increase the ... The primary objective of this safetymechanistic study is to determine the safety and tolerability of oral
—Cellcept when

compared with weekly intramuscular ... Consumer information about the medication MYCOPHENOLATE MOFETIL HYDROCHLORIDE - INJECTION (Cellcept), includes side effects, drug interactions, ... Participating patients will be randomly assigned to receive either Rebif® therapy alone or in combination with CellCept®. This is a single center trial ... Studies in 2003 and 2004 have shown that in patients with severe lupus nephritis, CellCept is as effective as daily cyclophosphamide and superior to monthly ... The companies said preliminary results from
—Aspreva's